-
Sector Analysis
New![]()
Turkey Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
Turkey Baby Food Market Report Overview The Turkey baby food market size was valued at TRY2.9 billion ($174.2 million) in 2022. The market is expected to achieve a CAGR of more than 20% during 2022-2028. Turkey Baby Food Market Outlook, 2022-2028 (TRY Billion) Buy the Full Report for More Insights on the Turkey Baby Food Market Forecast, Download A Free Report Sample The Turkey baby food market research report provides extensive and highly detailed current and future market trends in...
-
Sector Analysis
![]()
Australia Baby Food Market Size and Share by Categories, Distribution and Forecast to 2028
Australia Baby Food Market Report Overview The Australia baby food market size was AUD508.3 million ($352.4 million) in 2022. The market is expected to achieve a CAGR of more than 4% during 2022-2028. During 2016-2022, per capita consumption of baby finger food decreased. Australia Baby Food Market Outlook, 2022-2028 (AUD Million) Buy Full Report for More Insights on the Australia Baby Food Market Forecast Download A Free Report Sample The Australia Baby Food market research report provides extensive and highly detailed...
-
Company Profile
![]()
Oxurion NV – Company Profile
Oxurion NV (Oxurion), formerly ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer therapeutics. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreomacular adhesion (VMA) and vitreomacular traction (VMT). Oxurion’s product pipeline includes THR-687, a pan-RGD integrin antagonist being developed for the treatment of diabetic retinopathy, and THR-149, a plasma kallikrein inhibitor, for the treatment of diabetic macular edema (DME). It has commercialization agreements...
Add to Basket -
Sector Analysis
![]()
Peru Baby Food Market Size by Categories, Distribution Channel, Market Share and Forecast, 2022-2027
Peru Baby Food Market Report Overview The Peru baby food market size was valued at PEH877.1 million ($226 million) in 2021 and is expected to achieve a CAGR of less than 2% during 2021-2027. Baby milks dominated the Peruvian baby food sector and Nestlé remained the overall market leader in 2021. The Peru baby food market research report provides extensive and highly detailed current and future market trends in the Peru market. Peru Baby Food Market Outlook For more insights on...
-
Sector Analysis
![]()
China Baby Food Market Size by Categories, Distribution Channel, Market Share and Forecast, 2022-2027
China baby food market size was $12.24 billion in the year 2021. The market is expected to grow at a CAGR of more than 7% during the period 2021-2027. China baby food market research report provides consumption data based upon a unique combination of industry research, fieldwork, market sizing work and our in-house expertise to offer extensive data about the trends and dynamics affecting the industry.
-
Product Insights
![]()
Myasthenia Gravis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H1, 2018" provides an overview of Myasthenia Gravis clinical trials scenario. This report provides top line data relating to the clinical trials on Myasthenia Gravis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
![]()
Mycobacterium Infections Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Mycobacterium Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Mycobacterium Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
![]()
Cigarettes in the Philippines, 2017
"Cigarettes in the Philippines, 2017", is an analytical report by GlobalData that provides extensive and highly detailed current and future market trends in the the Philippine market. It covers market size and structure along with per capita and overall consumption. Additionally, it focuses on brand data, retail pricing, prospects and forecasts for sales and consumption to 2025. The cigarette market in the Philippines is large despite falling back recently. Although legitimate duty paid consumption was reported down by 12.1% to...
-
Product Insights
![]()
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2017" provides an overview of Gram-Positive Bacterial Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Gram-Positive Bacterial Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
![]()
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.